▎ 摘 要
NOVELTY - Proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibody containing sustained-release patch comprises a delivery system and medicine, where the delivery system comprises a matrix and metal nanoparticles and the medicine is PCSK9 monoclonal antibody. USE - The PCSK9 monoclonal antibody sustained-release patch is used as medicine for treating atherosclerosis (claimed).